PER 0.00% 9.9¢ percheron therapeutics limited

Chart, page-4320

  1. 218 Posts.
    lightbulb Created with Sketch. 81
    I mean they could go alone, but it’s incredibly risky. The PRV would likely go for 80-100M USD which would cover their P2B EMA + Dual FDA preclin/clin trials, but likely would dry up and not cover the later phase 2 trials for the FDA. I doubt ANP management want to try and tackle these pipelines by themselves, but I could be wrong.0
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.9¢
Change
0.000(0.00%)
Mkt cap ! $89.25M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 50193 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 100000 1
View Market Depth
Last trade - 07.03am 26/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.